Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
CRO
Biotech
Do we need new Alzheimer's scales, or a new perspective?
Scales to assess Alzheimer’s are not nearly sensitive enough. Do we throw them out and start over? A new study says we work with what we’ve got.
Annalee Armstrong
Feb 7, 2023 7:00am
GSK's trial diversity study shows there's more work to do
Feb 6, 2023 10:29am
CVS partners with ProKidney to enroll patients for phase 3 trial
Feb 2, 2023 8:10am
IQVIA partners with Alibaba Cloud to expand services in China
Feb 2, 2023 8:00am
Paradigm debuts with $203M series A funding
Jan 31, 2023 3:20pm
Crown Bioscience, JSR team to acquire IndivuServ unit
Jan 31, 2023 3:10pm
